2020 annual financial data
Aquestive Therapeutics 2020 Operating margin
Direct answer
Operating margin was -93.55%.
Operating income was -42,893,000 USD and net income was -55,783,000 USD.
Operating cash flow was -45,459,000 USD.
Get free Aquestive Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 45,849,000 USD
- Operating income
- -42,893,000 USD
- Net income
- -55,783,000 USD
- Operating cash flow
- -45,459,000 USD